The efficacy of octreotide LAR as firstline therapy for patients with newly diagnosed acromegaly is independent of tumor extension: predictive factors of tumor and biochemical response.
暂无分享,去创建一个
R. Casamitjana | J. Moreiro | M. Luque‐Ramírez | I. Halperin | C. Varela | A. Soto | G. R. Portolés | R. Albero